SNES Share Price Performance
US$0.86
-4.01 (-82.27%)
91.4% undervalued intrinsic discount
US$10.00
Fair Value
Price US$0.86
AnalystConsensusTarget US$10.00
AnalystHighTarget US$10.00
AnalystLowTarget US$3.50
Fair ValueUS$10.00
Share Pricen/a
SenesTech, Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
SNES Community Narratives
AN
Fair Value
·Fair Value US$10 91.4% undervalued intrinsic discount
Non-toxic Fertility Control Will Broaden Global Rodent Control Markets
1users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value
·Fair Value US$10 91.4% undervalued intrinsic discount
Fertility Control Demand And Recurring Subscriptions Will Support Strong Long Term Upside
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value
·Fair Value US$3.5 75.3% undervalued intrinsic discount
Early Stage Subscription And B2B Headwinds Will Shape Future Rodent Control Opportunity
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
SenesTech
91.4% undervalued intrinsic discount
Fertility Control Demand And Recurring Subscriptions Will Support Strong Long Term Upside
View narrativeAN
Published 14 Jun
SenesTech
75.3% undervalued intrinsic discount
Early Stage Subscription And B2B Headwinds Will Shape Future Rodent Control Opportunity
View narrativeAN
Published 31 May
SenesTech
91.4% undervalued intrinsic discount
Non-toxic Fertility Control Will Broaden Global Rodent Control Markets
View narrativeAN
Updated 1 May 2025
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
Fertility Control Demand And Recurring Subscriptions Will Support Strong Long Term Upside
Fair Value: US$10 91.4% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Early Stage Subscription And B2B Headwinds Will Shape Future Rodent Control Opportunity
Fair Value: US$3.5 75.3% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Non-toxic Fertility Control Will Broaden Global Rodent Control Markets
Fair Value: US$10 91.4% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
SenesTech, Inc. Key Details
Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
- -1.29
- 66.18%
- -294.73%
- 2.9%
About SNES
- Founded
- 2004
- Employees
- 24
- CEO
- WebsiteView website
SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption. It also develops Evolve Mouse, a modified version of its bait technology containing the active ingredient cottonseed oil that limits reproduction of male and female mice. The company was incorporated in 2004 and is headquartered in Surprise, Arizona.
